Growth and development in sickle cell disease;Crescimento e desenvolvimento nas doenças falciformes

Revista Brasileira de Hematologia e Hemoterapia

Volumn 29, Issue 3, 2007, Pages 271-274

  Verissimo, Monica P A ^a,b  

^a CENTRO INFANTIL BOLDRINI   (Brazil)

^b Cidade Universitaria   (Brazil)

Author keywords

Development; Growth; Puberty; Sickle cell disease

Indexed keywords

EID: 38049105803     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Stevens MCG, Maude GH, Cupidore L, et al. Prepubertal growth and skeletal maturation in children with sickle cell disease. Pediatrics. 1986;78:124-32.
2. Zago MA, Kerbauy J, Souza HM, Figueiredo MS, Costa FF, Cruz SM, et al. Growth and sexual maturation of Brazilian patients with sickle cell diseases. Trop Geogr Med. 1992;44:317-21.
3. Henderson RA, Saavedra JM, Dover GJ. Prevalence of impaired growth in children with homozygous sickle cell disease. Am J Med Sci. 1994;307:105-7.
4. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopaties on growth and development. N Engl J Med 1984;311:7-12.
5. Phebus CK, Gloninger MF, Maciak BJ. Growth patterns by age and sex in children with sickle cell disease. J Pediatr. 1984;105:28-33.
6. Modebe O, Ifenu SA. Growth retardation in homozygous sickle cell disease: role of calorie intake and possible gender - related differences. Am J Hematol. 1993;44:149-54.
7. Cipolotti R, Caskey MF, Franco RP, Mello EV, Dal Fabbro AL, Gurgel RQ et al. Childhood and adolescent growth of patients with sickle cell disease in Aracaju, Sergipe, north-east Brazil. Ann Trop Paediatr. 2000;20:109-13.
8. Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene Frempong K et al. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr. 2002;140:225-9.
9. Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood. 2005 1;106:2269-75.
10. Wang WC, Morales KH, Scher CD, Styles L, Olivieri N, Adams R et al. Effect of long-term transfusion on growth in children with sickle cell anemia:results of the STOP trial. J Pediatr. 2005;147:244-7.
11. Singhal A, Thomas P, Cook R, Wierenga K, Serjeant G. Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Child. 1994;71(5):404-8.
12. Buison AM, Kawchak DA, Schall JI, Ohene-Frempong K, Stallings VA, Leonard MB et al. Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics. 2005;116:943-9.
13. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006;47:901-6.
14. Serjeant GR, Singhal A, Hambleton IR. Sickle cell disease and age at menarche in Jamaican girls: observations from a cohort study. Arch Dis Child. 2001;85:375-8.
15. Leonard MB, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr. 1998;132:467-71.
16. Pellegrini Braga JA, Kerbauy J, Fisberg M. Zinc, copper and iron and their interrelations in the growth of sickle cell patients. Arch Latinoam Nutr. 1995;45:198-203.
17. Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR. Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr. 1993;57:32-4.
18. Salman EK, Haymond MW, Bayne E, Sager BK, Wiisanen A, Pitel P et al. Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res. 1996;40(1):34-40.
19. Williams R, Olivi S, Li CS, Storm M, Cremer L, Mackert P et al. Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 2004;26:619-25.
20. Soliman AT, el Banna N, alSalmi I, De Silva V, Craig A, Asfour M. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I)and IGF binding protein-3 concentrations in children with sickle cell disease. Metabolism. 1997;46:1241-5.
21. Soliman AT, Darwish A, Mohammed SH, Bassiony MR, el Banna N, Asfour M. Circulating growth hormone (GH), insulin-like growth factor-I (IGF-I) and free thyroxine, GH response to clonidine provocation and CT scanning of the hypothalamic-pituitary area in children with sickle cell disease. J Trop Pediatr. 1995;41:285-9.
22. El-Hazmi MA, Bahakim HM, al-Fawaz I. Endocrine functions in sickle cell anaemia patients.J Trop Pediatr. 1991;38:307-13.
23. Dada OA, Nduka EU. Endocrine function and haemoglobinopathies: relation between the sickle cell gene and circulating plasma levels of testosterone, luteinising hormone (LH) and follicle stimulating hormone (FSH) in adult males. Clin Chim Acta. 1980; 105 (2):269-73.
24. Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, et al. Multi-Centre Study of Iron Overload Research Group. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.Br J Haematol. 2006; 135:574-82.
25. Vichinsky E, Butensky E, Fung E, Hudes M, Theil E, Ferrell L et al. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol. 2005; 80:70-4.